increased prolactinoma incidence_Tg(Prl-EGFR)#Sme/0

http://metadb.riken.jp/0003505NSTgPrlEGFRSme0TgPrlEGFRSme

increased prolactinoma incidence_Tg(Prl-EGFR)#Sme/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion, Shlomo Melmed
  http://metadb.riken.jp/db/mgi_rdf/MGI:5696740

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Prl-EGFR)#Sme/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Prl-EGFR)#Sme

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• Not Specified

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased prolactinoma incidence
  http://purl.obolibrary.org/obo/MP_0003505

文献

http://purl.org/net/cito/citesAsAuthority

• Xiaohai. Liu, et.al., ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice., Endocrinology, 2015, 156
  http://rdf.ncbi.nlm.nih.gov/pubmed/25375038